{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T17:03:48Z","timestamp":1786122228259,"version":"build-2736575974"},"reference-count":18,"publisher":"Informa UK Limited","issue":"17","license":[{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"funder":[{"name":"Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Future Oncology"],"published-print":{"date-parts":[[2026,7,15]]},"DOI":"10.1080\/14796694.2026.2693604","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T11:02:15Z","timestamp":1783076535000},"page":"2067-2072","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Physician perspectives on the decision-making process for patients with high-risk early-stage triple-negative breast cancer in a community oncology setting"],"prefix":"10.1080","volume":"22","author":[{"given":"Amin","family":"Haiderali","sequence":"first","affiliation":[{"name":"Merck & Co., Inc","place":["Rahway, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda A.","family":"Okoth","sequence":"additional","affiliation":[{"name":"Ontada","place":["Boston, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinivas","family":"Annavarapu","sequence":"additional","affiliation":[{"name":"Ontada","place":["Boston, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica K.","family":"Paulus","sequence":"additional","affiliation":[{"name":"Ontada","place":["Boston, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilbur","family":"Pan","sequence":"additional","affiliation":[{"name":"Merck & Co., Inc","place":["Rahway, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Conkling","sequence":"additional","affiliation":[{"name":"Ontada","place":["Boston, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Danso","sequence":"additional","affiliation":[{"name":"The US Oncology Network","place":["Norfolk, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,7,3]]},"reference":[{"key":"e_1_3_8_3_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI45014"},{"key":"e_1_3_8_4_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1001389"},{"key":"e_1_3_8_5_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1910549"},{"key":"e_1_3_8_6_1","unstructured":"US Food & Drug Administration. FDA approves pembrolizumab for high-risk early-stage triple-negative breast cancer 2021. Available from: https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-disco-burst-edition-fda-approval-keytruda-pembrolizumab-high-risk-early-stage-triple-negative"},{"key":"e_1_3_8_7_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.00503"},{"key":"e_1_3_8_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2023.08.017"},{"key":"e_1_3_8_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.breast.2025.104040"},{"key":"e_1_3_8_10_1","doi-asserted-by":"publisher","DOI":"10.1158\/1557-3265.SABCS25-PS5-05-07"},{"key":"e_1_3_8_11_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.33.1744"},{"key":"e_1_3_8_12_1","unstructured":"USDA Economic Research Service. Rural-urban commuting area codes. 2020. Available from: https:\/\/www.ers.usda.gov\/data-products\/rural-urban-commuting-area-codes\/documentation"},{"key":"e_1_3_8_13_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2409932"},{"key":"e_1_3_8_14_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2112651"},{"key":"e_1_3_8_15_1","doi-asserted-by":"publisher","DOI":"10.1200\/EDBK_389516"},{"key":"e_1_3_8_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2024.02.002"},{"key":"e_1_3_8_17_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1612645"},{"key":"e_1_3_8_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-022-04189-6"},{"key":"e_1_3_8_19_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-03415-7"},{"key":"e_1_3_8_20_1","doi-asserted-by":"publisher","DOI":"10.1200\/EDBK_390464"}],"container-title":["Future Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14796694.2026.2693604","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/14796694.2026.2693604","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14796694.2026.2693604","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T08:42:54Z","timestamp":1786092174000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14796694.2026.2693604"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,3]]},"references-count":18,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2026,7,15]]}},"alternative-id":["10.1080\/14796694.2026.2693604"],"URL":"https:\/\/doi.org\/10.1080\/14796694.2026.2693604","relation":{},"ISSN":["1479-6694","1744-8301"],"issn-type":[{"value":"1479-6694","type":"print"},{"value":"1744-8301","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,3]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-12-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-19","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-03","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}